Dapagliflozin, a SGLT2 inhibitor, slows the progression of renal complications through the suppression of renal inflammation, ER stress, and apoptosis in pre ‐diabetic rats

Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-.

Source: Diabetes, Obesity and Metabolism - June 20, 2018 Category: Endocrinology Authors: Krit Jaikumkao , Anchalee Pongchaidecha , Nuttawud Chueakula , La ‐ongdao Thongnak , Keerati Wanchai , Varanuj Chatsudthipong , Nipon Chattipakorn , Anusorn Lungkaphin Source Type: research